A large-scale, multicenter study has shown that therapeutic hypothermia does not improve survival rates or reduce brain injury in infants and children with out-of-hospital cardiac arrest more than normal temperature control.

The Medicines Company announced that the U.S. Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) voted 9 - 2 with one abstention to recommend approval of the investigational intravenous antiplatelet agent...

Biotronik announced that the U.S. Food and Drug Administration (FDA) has approved its DX line of implantable cardioverter defibrillators (ICDs) that can deliver ultra-high energy on the first shock. Also included in the approval response from the...

Scientific confirmation has just been published in the American Journal of Cardiovascular Disease that atherosclerosis, the underlying process of heart attacks and strokes, is generally not caused by high cholesterol blood levels. It is r...

Video Center

Carestream, IHE-Europe Connectathon, Clinical Collaboration Platform, CCP
Carestream showcased the advanced interoperability of its Clinical Collaboration Platform (CCP) at the IHE-Europe (Integrating the Healthcare Enterprise)...
EMRs, information technology, KLAS, Epic, Cerner, Meditech, progress, usability
Research firm KLAS released a new report on electronic medical record (EMR) usability and product performance over the past two years, revealing how physicians...
Lantheus, flurpiridaz F 18, ICNC12, SPECT, CAD, PET, MPI, myocardial perfusion
Results from Lantheus Medical Imaging Inc.’s first Phase 3 study of flurpiridaz F 18 for myocardial perfusion imaging (MPI) were presented at the International...
therapeutic hypothermia, children, cardiac arrest, treatment, temperature
A large-scale, multicenter study has shown that therapeutic hypothermia does not improve survival rates or reduce brain injury in infants and children with out...
Biotronik, DX, ICD, Inventra, Itrevia, FDA, ultra-high energy
Biotronik announced that the U.S. Food and Drug Administration (FDA) has approved its DX line of implantable cardioverter defibrillators (
The cryoICE cryo ablation probe (CRYO2) from AtriCure Inc. is designed to provide cryoanalgesia for temporary pain management. It is the...
The Emblem Subcutaneous Implantable Defibrillator (S-ICD) system from Boston Scientific Corp. is a treatment option that provides...
The Watchman left atrial appendage closure device from Boston Scientific Corp. is a catheter-delivered heart implant designed to close the...
therapeutic hypothermia, children, cardiac arrest, treatment, temperature
A large-scale, multicenter study has shown that therapeutic hypothermia does not improve survival rates or reduce brain injury in infants and children with out...
Watchman, LAA, left atrial appendage
The long awaited U.S. Food and Drug Administration (FDA) approval of the first transcatheter left atrial appendage (LAA) occluder in March is seen by many...
Kaiba was just a newborn when he turned blue because his little lungs weren’t getting the oxygen they needed. Garrett spent the first year of his life in...
3D printing, 3-D printing
Several futuristic technologies and their potential impact on healthcare were discussed during the Future of Cardiovascular Medicine track sessions at the...
U.S. healthcare reform is largely being driven through adoption of new information technology (IT...
1 week 4 days ago
The biggest technology news coming out of the 2015 American College of Cardiology (ACC) annual...
5 weeks 4 days ago
It’s been no secret that the American healthcare system needed to change to survive economically...
11 weeks 4 days ago
Centricity, webinar, ZFV, ZFP, viewer, remote viewing system, enterprise
Healthcare organizations are demanding more capabilities for image viewers accessed by clinicians. Zero footprint (ZFP) viewers provide imaging tools from...
The webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" educates participants about the state of the art clinical and emerging translational...
This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and...

daic newsletter

Subscribe  UnSubscribe 
HTML  Text
more information

January 5, 2015 — The first large-scale, multispecialty prospective clinical research trial to evaluate the use of...
January 27, 2015 — Health and Human Services Secretary Sylvia M. Burwell announced measurable goals and a timeline...
The U.S. Food and Drug Administration (FDA) has granted approval of Medtronic’s premarket approval application (PMA)...

Click on a year to see the issues for that year.